Your Cart ( 1 Item )

• Adjunctive Use of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Patients With Psoriasis Treated With Ixekizumab
  March 2022 | Volume 21 | Issue 3 | Original Article | 235 | Copyright © March 2022
  Jerry Bagel MD MS, Elise Nelson LPN CCRC
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs